Your Shopping Cart Is Empty
| Report Code: A01590 | Feb 2017 | Pages: 240 | ||
| Tables: 54 | Charts: 78 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Intraoperative Neuromonitoring Market
Request Now !Global intraoperative neuromonitoring market size was valued at $3,036 million in 2015, and is expected to reach $4,900 million by 2022, growing at a CAGR of 7.0% during the forecast period. Intraoperative neurophysiological monitoring (IONM) or intraoperative neuromonitoring is a technique that reduces the risk of neurological deficits during and after surgeries involving nervous system. An IONM system uses recordings of potentials (such as EEG, EMG, and evoked potentials) from the nervous system during a surgical procedure. The use of neuromonitoring is important during surgeries as it helps in detection of injuries before they become so severe that they cause post-operative complications in the patients. Therefore, IONM reduces risk of debilitating deficits such as muscle weakness, paralysis, hearing loss, and other normal body functions.
Ageing population, increase in prevalence of chronic disorders, applications of IONM in different surgeries, and risk management through IONM during complex surgeries drive the market. However, the market growth is limited due to dearth of skilled professionals and low awareness of IONM in the developing nations. Conversely, increase in medical tourism and growth opportunities in the emerging economies of the Asia-Pacific and LAMEA regions are expected to provide several opportunities for market growth during the forecast period.
Segment Review
Intraoperative neuromonitoring market analysis shows that IONM has its applications in various surgical procedures such as spine surgery, neurosurgery, vascular surgery, ENT surgery, orthopedic surgery, and other surgeries where there is involvement of nervous system. IONM has become an important tool to minimize post-operative injuries. Wide applications of IONM along with a global rise in the number of surgeries majorly drives the IONM market. According to WHO, an estimated 266.2 to 359.5 million surgeries were performed globally in 2012. This represented an increase of 38% over the previous eight years. The estimates also demonstrated that largest increase in the number of surgeries was observed in very-low- and low-expenditure Member States of the UNO. This is anticipate to lead to growth of intraoperative neuromonitoring industry as the target consumers are not limited to any specific age group, gender, or disease type.
Shift towards Outsourced Monitoring
Outsourced IONM monitoring is growing at a fast pace due to its benefits over insourced monitoring. Now-a-days, hospitals generally do not prefer insourced monitoring as they have to appoint a full-time employee with the required skill set and they cannot offer the training standardization that is required to improve the quality of service. Thus, outsourced monitoring is in demand among hospitals and ASCs. In addition, IONM professionals also prefer to work for an outsourcing provider as they can work simultaneously for more than one hospital by working in an outsourcing IONM provider. Thus, the outsourcing intraoperative neuromonitoring market is expected to witness a high growth throughout the forecast period. Moreover, an outsourced provider can purchase one device and work for many hospitals in the same local area.
Top Investment Pockets
ENT surgery and orthopedic surgery are attractive areas of investment in IONM market as these surgeries pose a potential risk to the neural structures and require a technique which protects nerves (and other related structures) during the procedure. Thus, orthopedic and ENT surgeries are prominent areas for investment in IONM market.
Clinical Trials
As IONM is a new field, there are few clinical trials in IONM market. Europe accounted for the maximum number of trials (12) in the market followed by North America (11). Asia-Pacific and LAMEA accounted for a small share (one clinical trial in each region) in the intraoperative neuromonitoring market.
The list of key players profiled in this report include Medtronic plc, NuVasive, Inc., Computational Diagnostics, Inc., SpecialtyCare, Natus Medical Incorporated., IntraNerve, LLC, inomed Medizintechnik GmbH, Accurate Monitoring LLC, Nihon Kohden Corporation and Moberg Research, Inc. Key players in the value chain include Argos Neuromonitoring LP, Medsurant Holdings, LLC, NeuroMonitoring Technologies, Inc. and Cadwell Industries, Inc.
Key Benefits for Stakeholders
Intraoperative Neuromonitoring Market Report Highlights
| Aspects | Details |
|---|---|
| By PRODUCT & SERVICE |
|
| By SOURCE TYPE |
|
| By MODALITY |
|
| By APPLICATION |
|
| By END USER |
|
| By Region |
|
| Key Market Players | ACCURATE MONITORING LLC, NUVASIVE, INC., MEDTRONIC PLC, SPECIALTYCARE, INOMED MEDIZINTECHNIK GMBH, NATUS MEDICAL INCORPORATED, MOBERG RESEARCH, INC. (DAYONE MEDICAL, LLC.), INTRANERVE, LLC, COMPUTATIONAL DIAGNOSTICS, INC., NIHON KOHDEN CORPORATION |
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.2.1. Competitive intelligence of companies and their strategies
3.3. PLAYER POSITIONING, 2015
3.4. MARKET DYNAMICS
3.4.1. Drivers
3.4.1.1. Growing geriatric population
3.4.1.2. Increasing prevalence of chronic disorders
3.4.1.3. Applications of IONM in various surgeries
3.4.1.4. Risk management through IONM during complex surgeries
3.4.2. Restraints
3.4.2.1. Low awareness of IONM in developing nations
3.4.2.2. Dearth of skilled professionals
3.4.3. Opportunities
3.4.3.1. Increasing trend of medical tourism
3.4.3.2. Growth opportunities in emerging economies
3.4.4. Impact analysis
3.5. CLINICAL TRIALS
3.6. REIMBURSEMENT SCENARIO IN THE U.S.
CHAPTER 4 INTRAOPERATIVE NEUROMONITORING MARKET, BY PRODUCT & SERVICE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. SYSTEMS
4.2.1. Market size and forecast
4.3. ACCESSORIES
4.3.1. Market size and forecast
4.4. SERVICES
4.4.1. Market size and forecast
CHAPTER 5 INTRAOPERATIVE NEUROMONITORING MARKET, BY SOURCE TYPE
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. INSOURCED MONITORING
5.2.1. Key market trends
5.2.2. Key growth factors and opportunities
5.2.3. Market size and forecast
5.3. OUTSOURCED MONITORING
5.3.1. Key market trends
5.3.2. Key growth factors and opportunities
5.3.3. Market size and forecast
CHAPTER 6 INTRAOPERATIVE NEUROMONITORING MARKET, BY MODALITY
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. SOMATOSENSORY EVOKED POTENTIALS (SSEPS)
6.2.1. Market size and forecast
6.3. ELECTROMYOGRAPHY (EMG)
6.3.1. Market size and forecast
6.4. ELECTROENCEPHALOGRAPHY (EEG)
6.4.1. Market size and forecast
6.5. BRAINSTEM AUDITORY EVOKED POTENTIALS (BAEPS)
6.5.1. Market size and forecast
6.6. MOTOR EVOKED POTENTIALS (MEPS)
6.6.1. Market size and forecast
6.7. VISUAL EVOKED POTENTIALS (VEPS)
6.7.1. Market size and forecast
CHAPTER 7 INTRAOPERATIVE NEUROMONITORING MARKET, BY APPLICATION
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. SPINAL SURGERY
7.2.1. Market size and forecast
7.3. ENT SURGERY
7.3.1. Market size and forecast
7.4. NEUROSURGERY
7.4.1. Market size and forecast
7.5. VASCULAR SURGERY
7.5.1. Market size and forecast
7.6. ORTHOPEDIC SURGERY
7.6.1. Market size and forecast
7.7. OTHER SURGERIES
7.7.1. Market size and forecast
CHAPTER 8 INTRAOPERATIVE NEUROMONITORING MARKET, BY END USER
8.1. OVERVIEW
8.1.1. Market size and forecast
8.2. HOSPITALS
8.2.1. Market size and forecast
8.3. AMBULATORY SURGICAL CENTERS (ASCS)
8.3.1. Market size and forecast
CHAPTER 9 INTRAOPERATIVE NEUROMONITORING MARKET, BY REGION
9.1. OVERVIEW
9.1.1. Market size and forecast
9.2. NORTH AMERICA
9.2.1. Key market trends
9.2.2. Key growth factors and opportunities
9.2.3. Market size and forecast
9.2.4. U.S.
9.2.5. Canada
9.2.6. Mexico
9.3. EUROPE
9.3.1. Key market trends
9.3.2. Key growth factors and opportunities
9.3.3. Market size and forecast
9.3.4. Germany
9.3.5. France
9.3.6. UK
9.3.7. Italy
9.3.8. Spain
9.3.9. Rest of Europe
9.4. ASIA-PACIFIC
9.4.1. Key market trends
9.4.2. Key growth factors and opportunities
9.4.3. Market size and forecast
9.4.4. Japan
9.4.5. China
9.4.6. India
9.4.7. South Korea
9.4.8. Australia
9.4.9. Rest of Asia-Pacific
9.5. LAMEA
9.5.1. Key market trends
9.5.2. Key growth factors and opportunities
9.5.3. Market size and forecast
9.5.4. Brazil
9.5.5. South Africa
9.5.6. Saudi Arabia
9.5.7. Rest of LAMEA
CHAPTER 10 COMPANY PROFILES
10.1. ACCURATE MONITORING LLC
10.1.1. Company overview
10.1.2. Operating business segments
10.1.3. Business performance
10.2. COMPUTATIONAL DIAGNOSTICS, INC.
10.2.1. Company overview
10.2.2. Operating business segments
10.2.3. Business performance
10.3. INTRANERVE, LLC
10.3.1. Company overview
10.3.2. Operating business segments
10.3.3. Business performance
10.4. INOMED MEDIZINTECHNIK GMBH
10.4.1. Company overview
10.4.2. Operating business segments
10.4.3. Business performance
10.4.4. Key strategic moves and developments
10.5. MEDTRONIC PLC
10.5.1. Company overview
10.5.2. Operating business segments
10.5.3. Business performance
10.6. MOBERG RESEARCH, INC. (DAYONE MEDICAL, LLC.)
10.6.1. Company overview
10.6.2. Operating business segments
10.6.3. Business performance
10.6.4. Key strategic moves and developments
10.7. NATUS MEDICAL INCORPORATED
10.7.1. Company overview
10.7.2. Operating business segments
10.7.3. Business performance
10.7.4. Key strategic moves and developments
10.8. NIHON KOHDEN CORPORATION
10.8.1. Company overview
10.8.2. Operating business segments
10.8.3. Business performance
10.8.4. Key strategic moves and developments
10.9. NUVASIVE, INC.
10.9.1. Company overview
10.9.2. Operating business segments
10.9.3. Business performance
10.9.4. Key strategic moves and developments
10.10. SPECIALTYCARE
10.10.1. Company overview
10.10.2. Operating business segments
10.10.3. Business performance
10.10.4. Key strategic moves and developments
LIST OF TABLES
TABLE 1. COMPLETED CLINICAL TRIALS IN IONM MARKET
TABLE 2. BASE (PRIMARY) CODES FOR IONM MODALITIES
TABLE 3. HOSPITAL INPATIENT CODES
TABLE 4. GLOBAL IONM MARKET, BY PRODUCT & SERVICE, 2014-2022 ($MILLION)
TABLE 5. IONM SYSTEMS MARKET, BY REGION, 2014-2022
TABLE 6. IONM ACCESSORIES MARKET, BY REGION, 2014-2022 (%MILLION)
TABLE 7. IONM SERVICES MARKET, BY REGION, 2014-2022 (%MILLION)
TABLE 8. GLOBAL IONM MARKET, BY SOURCE TYPE, 2014-2022 ($MILLION)
TABLE 9. INSOURCED IONM MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 10. OUTSOURCED IONM MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 11. GLOBAL IONM MARKET, BY MODALITY, 2014-2022 ($MILLION)
TABLE 12. GLOBAL IONM MARKET, BY APPLICATION, 2014-2022 ($MILLION)
TABLE 13. IONM MARKET FOR SPINAL SURGERY, BY REGION, 2014-2022 ($MILLION)
TABLE 14. IONM MARKET FOR ENT SURGERY, BY REGION, 2014-2022 ($MILLION)
TABLE 15. IONM MARKET FOR NEUROSURGERY, BY REGION, 2014-2022 ($MILLION)
TABLE 16. IONM FOR VASCULAR SURGERY, BY REGION, 2014-2022 ($MILLION)
TABLE 17. IONM MARKET FOR ORTHOPEDIC SURGERY, BY REGION, 2014-2022 ($MILLION)
TABLE 18. IONM MARKET FOR OTHER SURGERIES, BY REGION, 2014-2022 ($MILLION)
TABLE 19. GLOBAL IONM MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 20. IONM MARKET FOR HOSPITALS, BY REGION, 2014-2022 ($MILLION)
TABLE 21. IONM MARKET FOR AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2014-2022 ($MILLION)
TABLE 22. IONM MARKET, BY REGION, 2014-2022 ($MILLION)
TABLE 23. NORTH AMERICA IONM MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 24. NORTH AMERICA IONM MARKET, BY PRODUCT & SERVICE, 2014-2022 ($MILLION)
TABLE 25. NORTH AMERICA IONM MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 26. EUROPE IONM MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 27. EUROPE IONM MARKET, BY PRODUCT & SERVICE, 2014-2022 ($MILLION)
TABLE 28. EUROPE IONM MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 29. ASIA-PACIFIC IONM MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 30. ASIA-PACIFIC IONM MARKET, BY PRODUCT & SERVICE, 2014-2022 ($MILLION)
TABLE 31. ASIA-PACIFIC IONM MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 32. LAMEA IONM MARKET, BY COUNTRY, 2014-2022 ($MILLION)
TABLE 33. LAMEA IONM MARKET, BY PRODUCT & SERVICE, 2014-2022 ($MILLION)
TABLE 34. LAMEA IONM MARKET, BY END USER, 2014-2022 ($MILLION)
TABLE 35. ACCURATE: COMPANY SNAPSHOT
TABLE 36. CDI: COMPANY SNAPSHOT
TABLE 37. CDI: OPERATING SEGMENTS
TABLE 38. INTRANERVE: COMPANY SNAPSHOT
TABLE 39. INTRANERVE: OPERATING SEGMENTS
TABLE 40. INOMED: COMPANY SNAPSHOT
TABLE 41. INOMED: OPERATING SEGMENTS
TABLE 42. MEDTRONIC: COMPANY SNAPSHOT
TABLE 43. MEDTRONIC: OPERATING SEGMENTS
TABLE 44. MOBERG: COMPANY SNAPSHOT
TABLE 45. MOBERG: OPERATING SEGMENTS
TABLE 46. NATUS: COMPANY SNAPSHOT
TABLE 47. NIHON: COMPANY SNAPSHOT
TABLE 48. NIHON: OPERATING SEGMENTS
TABLE 49. NUVASIVE: COMPANY SNAPSHOT
TABLE 50. NUVASIVE: PRODUCT LINES
TABLE 51. SPECIALTYCARE: COMPANY SNAPSHOT
TABLE 52. SPECIALTYCARE: OPERATING SEGMENTS
LIST OF FIGURES
FIGURE 1. IONM MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 5. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 6. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIGURE 7. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 8. MARKET PLAYER POSITIONING, 2015
FIGURE 9. IMPACT ANALYSIS: GLOBAL IONM MARKET
FIGURE 10. CLINICAL TRIALS IN THE GLOBAL IONM INDUSTRY
FIGURE 11. GLOBAL IONM MARKET, BY PRODUCT & SERVICE, 2014-2022 ($MILLION)
FIGURE 12. IONM SYSTEMS MARKET, BY REGION, 2014-2022 ($MILLION)
FIGURE 13. IONM ACCESSORIES MARKET, BY REGION, 2014-2022 ($MILLION)
FIGURE 14. IONM SERVICES MARKET, BY REGION, 2014-2022 ($MILLION)
FIGURE 15. GLOBAL IONM MARKET, BY SOURCE TYPE, 2014-2022 ($MILLION)
FIGURE 16. INSOURCED IONM MARKET, BY REGION, 2014-2022 ($MILLION)
FIGURE 17. OUTSOURCED IONM MARKET, BY REGION, 2014-2022 ($MILLION)
FIGURE 18. GLOBAL IONM MARKET, BY MODALITY, 2014-2022 ($MILLION)
FIGURE 19. GLOBAL IONM MARKET FOR SSEPS, 2014-2022 ($MILLION)
FIGURE 20. GLOBAL IONM MARKET FOR EMG, 2014-2022 ($MILLION)
FIGURE 21. GLOBAL IONM MARKET FOR EEG, 2014-2022 ($MILLION)
FIGURE 22. GLOBAL IONM MARKET FOR BAEPS, 2014-2022 ($MILLION)
FIGURE 23. GLOBAL IONM MARKET FOR MEPS, 2014-2022 ($MILLION)
FIGURE 24. GLOBAL IONM MARKET FOR VEPS, 2014-2022 ($MILLION)
FIGURE 25. GLOBAL IONM MARKET, BY APPLICATION, 2014-2022 ($MILLION)
FIGURE 26. IONM MARKET FOR SPINAL SURGERY, BY REGION, 2014-2022 ($MILLION)
FIGURE 27. IONM MARKET FOR ENT SURGERY, BY REGION, 2014-2022 ($MILLION)
FIGURE 28. IONM MARKET FOR NEUROSURGERY, BY REGION, 2014-2022 ($MILLION)
FIGURE 29. IONM FOR VASCULAR SURGERY, BY REGION, 2014-2022 ($MILLION)
FIGURE 30. IONM MARKET FOR ORTHOPEDIC SURGERY, BY REGION, 2014-2022 ($MILLION)
FIGURE 31. IONM MARKET FOR OTHER SURGERIES, BY REGION, 2014-2022 ($MILLION)
FIGURE 32. GLOBAL IONM MARKET, BY END USER, 2014-2022 ($MILLION)
FIGURE 33. IONM MARKET FOR HOSPITALS, BY REGION, 2014-2022 ($MILLION)
FIGURE 34. IONM MARKET FOR AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2014-2022 ($MILLION)
FIGURE 35. IONM MARKET, BY REGION, 2014-2022 ($MILLION)
FIGURE 36. NORTH AMERICA IONM MARKET, BY COUNTRY, 2014-2022 ($MILLION)
FIGURE 37. NORTH AMERICA IONM MARKET, BY PRODUCT & SERVICE, 2014-2022 ($MILLION)
FIGURE 38. NORTH AMERICA IONM MARKET, BY END USER, 2014-2022 ($MILLION)
FIGURE 39. U.S. IONM MARKET, 2014-2022 ($MILLION)
FIGURE 40. CANADA IONM MARKET, 2014-2022 ($MILLION)
FIGURE 41. MEXICO IONM MARKET, 2014-2022 ($MILLION)
FIGURE 42. EUROPE IONM MARKET, BY COUNTRY, 2014-2022 ($MILLION)
FIGURE 43. EUROPE IONM MARKET, BY PRODUCT & SERVICE, 2014-2022 ($MILLION)
FIGURE 44. EUROPE IONM MARKET, BY END USER, 2014-2022 ($MILLION)
FIGURE 45. GERMANY IONM MARKET, 2014-2022 ($MILLION)
FIGURE 46. FRANCE IONM MARKET, 2014-2022 ($MILLION)
FIGURE 47. UK IONM MARKET, 2014-2022 ($MILLION)
FIGURE 48. ITALY IONM MARKET, 2014-2022 ($MILLION)
FIGURE 49. SPAIN IONM MARKET, 2014-2022 ($MILLION)
FIGURE 50. REST OF EUROPE IONM MARKET, 2014-2022 ($MILLION)
FIGURE 51. ASIA-PACIFIC IONM MARKET, BY COUNTRY, 2014-2022 ($MILLION)
FIGURE 52. ASIA-PACIFIC IONM MARKET, BY PRODUCT & SERVICE, 2014-2022 ($MILLION)
FIGURE 53. ASIA-PACIFIC IONM MARKET, BY END USER, 2014-2022 ($MILLION)
FIGURE 54. JAPAN IONM MARKET, 2014-2022 ($MILLION)
FIGURE 55. CHINA IONM MARKET, 2014-2022 ($MILLION)
FIGURE 56. INDIA IONM MARKET, 2014-2022 ($MILLION)
FIGURE 57. SOUTH KOREA IONM MARKET, 2014-2022 ($MILLION)
FIGURE 58. AUSTRALIA IONM MARKET, 2014-2022 ($MILLION)
FIGURE 59. REST OF ASIA-PACIFIC IONM MARKET, 2014-2022 ($MILLION)
FIGURE 60. LAMEA IONM MARKET, BY COUNTRY, 2014-2022 ($MILLION)
FIGURE 61. LAMEA IONM MARKET, BY PRODUCT & SERVICE, 2014-2022 ($MILLION)
FIGURE 62. LAMEA IONM MARKET, BY END USER, 2014-2022 ($MILLION)
FIGURE 63. BRAZIL IONM MARKET, 2014-2022 ($MILLION)
FIGURE 64. SOUTH AFRICA IONM MARKET, 2014-2022 ($MILLION)
FIGURE 65. SAUDI ARABIA IONM MARKET, 2014-2022 ($MILLION)
FIGURE 66. REST OF LAMEA IONM MARKET, 2014-2022 ($MILLION)
FIGURE 67. MEDTRONIC: REVENUE, 2014-2016 ($MILLION)
FIGURE 68. MEDTRONIC: REVENUE BY SEGMENT, 2016 (%)
FIGURE 69. MEDTRONIC: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 70. NATUS: REVENUE, 2014-2016 ($MILLION)
FIGURE 71. NATUS: REVENUE BY PRODUCT FAMILY, 2016 (%)
FIGURE 72. NATUS: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 73. NIHON: REVENUE, 2014-2016 ($MILLION)
FIGURE 74. NIHON: REVENUE BY SEGMENT, 2016 (%)
FIGURE 75. NIHON: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 76. NUVASIVE: REVENUE, 2014-2016 ($MILLION)
FIGURE 77. NUVASIVE: REVENUE BY PRODUCT LINE, 2016 (%)
FIGURE 78. NUVASIVE: REVENUE BY GEOGRAPHY, 2016 (%)
There has been a remarkable increase in the use of IONM devices by hospitals and ambulatory surgical centers during complex surgeries. Moreover, the market is moving towards outsourced monitoring to provide advanced treatment options for patients suffering from chronic diseases. North America is projected to generate the highest revenue, whereas Asia-Pacific is expected to offer lucrative opportunities to the key players in this market.
Ageing population, increase in prevalence of chronic disorders, application of IONM in different surgeries, and risk management through IONM during complex surgeries drive the market. However, unawareness of IONM in developing nations and dearth of skilled professionals hamper the growth. Conversely, increase in medical tourism and growth opportunities in the emerging economies of the Asia-Pacific and LAMEA regions are expected to provide several opportunities for market growth during the forecast period. Majority of the manufacturers and distributors focus to expand their presence in emerging economies.
North America is expected to dominate the global IONM market during the forecast period due to high adoption of IONM services, better reimbursement policies, awareness among physicians and patients about IONM, and developed infrastructure.
Start reading instantly.
This Report and over 66,804+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Contact Details
Need to talk to an expert? Book your free consultation and let our research experts help you with your needs/problems.
Global Report 
Regional Report
Country Report
Related Report